Aβ-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease

Trends in Molecular Medicine

Volumn 16, Issue 6, 2010, Pages 287-294

  Huang, Yadong ^a  

^a GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; MESSENGER RNA; TAU PROTEIN;

ALZHEIMER DISEASE; CAUSAL ATTRIBUTION; CYTOSKELETON; GENE FUNCTION; GENE INTERACTION; GENE LOCATION; GENE STRUCTURE; GENETIC POLYMORPHISM; MITOCHONDRION; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; STRUCTURE ANALYSIS; TRANSGENIC MOUSE; ANIMAL; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM; NERVE CELL; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEIN E4; HUMANS; MODELS, BIOLOGICAL; NEURONS;

EID: 77953286012     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.04.004     Document Type: Review

References (123)

1. Mahley R.W. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240 (1988) 622-630
2. Weisgraber K.H. Apolipoprotein E: structure-function relationships. Adv. Protein Chem. 45 (1994) 249-302
3. Corder E.H., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261 (1993) 921-923
4. Saunders A.M., et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
5. Farrer L.A., et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. J. Am. Med. Assoc. 278 (1997) 1349-1356
6. Namba Y., et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541 (1991) 163-166
7. Wisniewski T., and Frangione B. Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135 (1992) 235-238
8. Strittmatter W.J., et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 1977-1981
9. Corder E.H., et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7 (1994) 180-184
10. Teasdale G.M., et al. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350 (1997) 1069-1071
11. Jordan B.D., et al. Apolipoprotein E ε4 associated with chronic traumatic brain injury in boxing. JAMA 278 (1997) 136-140
12. Friedman G., et al. Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52 (1999) 244-248
13. Chamelian L., et al. Six-month recovery from mild to moderate traumatic brain injury: The role of APOE-ε4 allele. Brain 127 (2004) 2621-2628
14. Alberts M.J., et al. ApoE genotype and survival from intracerebral haemorrhage. Lancet 346 (1995) 575
15. Slooter A.J., et al. Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation. J. Am. Med. Assoc. 277 (1997) 818-821
16. Harhangi B.S., et al. APOE and the risk of PD with or without dementia in a population-based study. Neurology 54 (2000) 1272-1276
17. Parsian A., et al. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. Genomics 79 (2002) 458-461
18. Li Y.J., et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology 62 (2004) 2005-2009
19. Schmidt S., et al. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am. J. Hum. Genet. 70 (2002) 708-717
20. Kantarci O.H., et al. Association of APOE polymorphisms with disease severity in MS is limited to women. Neurology 62 (2004) 811-814
21. Moulard B., et al. Apolipoprotein E genotyping in sporadic amyotrophic lateral sclerosis: Evidence for a major influence on the clinical presentation and prognosis. J. Neurol. Sci. 139 Suppl. (1996) 34-37
22. Drory V.E., et al. Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis. J. Neurol. Sci. 190 (2001) 17-20
23. Dong L.-M., et al. Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J. Biol. Chem. 269 (1994) 22358-22365
24. Dong L.-M., and Weisgraber K.H. Human apolipoprotein E4 domain interaction. Arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins. J. Biol. Chem. 271 (1996) 19053-19057
25. Xu Q., et al. Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer. J. Biol. Chem. 279 (2004) 25511-25516
26. Ye S., et al. Apolipoprotein (apo) E4 enhances amyloid β peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18700-18705
27. Mahley R.W., et al. Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5644-5651
28. Zhong N., and Weisgraber K.H. Understanding the association of apolipoprotein E4 with Alzheimer's disease: clues from its structure. J. Biol. Chem. 284 (2009) 6027-6031
29. Zhong N., et al. Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function. J. Biol. Chem. 284 (2009) 27273-27280
30. Raffaï R.L., et al. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11587-11591
31. Huang Y., et al. Apolipoprotein E. Diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease. J. Mol. Neurosci. 23 (2004) 189-204
32. Huang Y. Apolipoprotein E and Alzheimer disease. Neurology 66 Suppl. 1 (2006) S79-S85
33. Mahley R.W., and Huang Y. Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond. Curr. Opin. Lipidol. 10 (1999) 207-217
34. Weisgraber K.H., and Mahley R.W. Human apolipoprotein E: the Alzheimer's disease connection. FASEB J. 10 (1996) 1485-1494
35. Elshourbagy N.A., et al. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 203-207
36. Boyles J.K., et al. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system. J. Clin. Invest. 76 (1985) 1501-1513
37. Pitas R.E., et al. Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins. Biochim. Biophys. Acta 917 (1987) 148-161
38. Beffert U., and Poirier J. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. N.Y. Acad. Sci. 777 (1996) 166-174
39. Diedrich J.F., et al. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes. J. Virol. 65 (1991) 4759-4768
40. Han S.-H., et al. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study. J. Neuropathol. Exp. Neurol. 53 (1994) 535-544
41. Bao F., et al. Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain. Neuroreport 7 (1996) 1733-1739
42. Metzger R.E., et al. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease. J. Neuropathol. Exp. Neurol. 55 (1996) 372-380
43. s) is preferentially associated with neuron-enriched cultures from APOE transgenic mice. Neurobiol. Dis. 6 (1999) 63-75
44. Dekroon R.M., and Armati P.J. Synthesis and processing of apolipoprotein E in human brain cultures. Glia 33 (2001) 298-305
45. Xu P.-T., et al. Specific regional transcription of apolipoprotein E in human brain neurons. Am. J. Pathol. 154 (1999) 601-611
46. Messmer-Joudrier S., et al. Injury-induced synthesis and release of apolipoprotein E and clusterin from rat neural cells. Eur. J. Neurosci. 8 (1996) 2652-2661
47. Xu Q., et al. Profile and regulation of apolipoprotein E (apoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the apoE locus. J. Neurosci. 26 (2006) 4985-4994
48. Boschert U., et al. Apolipoprotein E expression by neurons surviving excitotoxic stress. Neurobiol. Dis. 6 (1999) 508-514
49. LeBlanc A.C., and Poduslo J.F. Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve. J. Neurosci. Res. 25 (1990) 162-171
50. Skene J.H.P., and Shooter E.M. Denervated sheath cells secrete a new protein after nerve injury. Proc. Natl. Acad. Sci. U. S. A. 80 (1983) 4169-4173
51. Müller H.W., et al. A specific 37,000-dalton protein that accumulates in regenerating but not in nonregenerating mammalian nerves. Science 228 (1985) 499-501
52. Ignatius M.J., et al. Expression of apolipoprotein E during nerve degeneration and regeneration. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 1125-1129
53. Boyles J.K., et al. A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve. J. Clin. Invest. 83 (1989) 1015-1031
54. Ignatius M.J., et al. Lipoprotein uptake by neuronal growth cones in vitro. Science 236 (1987) 959-962
55. Chen Y., et al. Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury. Neuroscience 80 (1997) 1255-1262
56. Poirier J., et al. Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience 55 (1993) 81-90
57. Masliah E., et al. Neurodegeneration in the central nervous system of apoE-deficient mice. Exp. Neurol. 136 (1995) 107-122
58. -/- mice: Isoform-specific effects on neurodegeneration. J. Neurosci. 19 (1999) 4867-4880
59. Buttini M., et al. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience 97 (2000) 207-210
60. Buttini M., et al. Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid β peptides but not on plaque formation. J. Neurosci. 22 (2002) 10539-10548
61. Raber J., et al. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10914-10919
62. Raber J., et al. Apolipoprotein E and cognitive performance. Nature 404 (2000) 352-354
63. Raber J., et al. Androgens protect against apolipoprotein E4-induced cognitive deficits. J. Neurosci. 22 (2002) 5204-5209
64. Hartman R.E., et al. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp. Neurol. 170 (2001) 326-344
65. Bour A., et al. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks. Behav. Brain Res. 193 (2008) 174-182
66. Nathan B.P., et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264 (1994) 850-852
67. Nathan B.P., et al. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J. Biol. Chem. 270 (1995) 19791-19799
68. Handelmann G.E., et al. Effects of apolipoprotein E, β-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J. Lipid Res. 33 (1992) 1677-1688
69. DeMattos R.B., et al. A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins. J. Biol. Chem. 273 (1998) 4206-4212
70. DeMattos R.B., et al. Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth. J. Lipid Res. 42 (2001) 976-987
71. Holtzman D.M., et al. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 9480-9484
72. Fagan A.M., et al. Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J. Biol. Chem. 271 (1996) 30121-30125
73. Sun Y., et al. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins. J. Neurosci. 18 (1998) 3261-3272
74. Bellosta S., et al. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J. Biol. Chem. 270 (1995) 27063-27071
75. Teter B., et al. Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function. J. Neurosci. Res. 68 (2002) 331-336
76. Qiu Z., et al. Apolipoprotein E receptors mediate neurite outgrowth through activation of p44/42 mitogen-activated protein kinase in primary neurons. J. Biol. Chem. 279 (2004) 34948-34956
77. Ji Y., et al. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients. Neuroscience 122 (2003) 305-315
78. Dumanis S.B., et al. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci. 29 (2009) 15317-15322
79. Brodbeck J., et al. Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons. PNAS 105 (2008) 1343-1346
80. Li G., et al. GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. Cell Stem Cell 5 (2009) 634-645
81. Levi O., and Michaelson D.M. Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice. J. Neurochem. 100 (2007) 202-210
82. Xu Q., et al. Intron-3 retention/splicing controls neuronal expression of apolipoprotein E in the central nervous system. J. Neurosci. 28 (2008) 1452-1459
83. Xu P.-T., et al. Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: Human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice. Neurobiol. Dis. 3 (1996) 229-245
84. Aoki K., et al. Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction. Stroke 34 (2003) 875-880
85. Dupont-Wallois L., et al. ApoE synthesis in human neuroblastoma cells. Neurobiol. Dis. 4 (1997) 356-364
86. Ferreira S., et al. Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons. Exp. Neurol. 166 (2000) 415-421
87. Huang Y., et al. Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 8838-8843
88. Harris F.M., et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10966-10971
89. Brecht W.J., et al. Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice. J. Neurosci. 24 (2004) 2527-2534
90. Biernat J., et al. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J. 11 (1992) 1593-1597
91. Goedert M., et al. Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8 (1992) 159-168
92. Lewis J., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat. Genet. 25 (2000) 402-405
93. Strittmatter W.J., et al. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp. Neurol. 125 (1994) 163-171
94. Strittmatter W.J., et al. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 11183-11186
95. Tesseur I., et al. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice. Am. J. Pathol. 156 (2000) 951-964
96. Tesseur I., et al. Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord. Am. J. Pathol. 157 (2000) 1495-1510
97. Inbar D., et al. Possible role of tau in mediating pathological effects of apoE4 in vivo prior to and following activation of the amyloid cascade. Neurodegener. Dis. 7 (2010) 16-23
98. Kobayashi M., et al. Phosphorylation state of tau in the hippocampus of apolipoprotein E4 and E3 knock-in mice. Neuroreport 14 (2003) 699-702
99. Harris F.M., et al. Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc. J. Biol. Chem. 279 (2004) 44795-44801
100. Chan A., et al. Dietary deficiency in folate and vitamin E under conditions of oxidative stress increases phospho-tau levels: potentiation by apoE4 and alleviation by S-adenosylmethionine. J. Alzheimers Dis. 17 (2009) 483-487
101. Ljungberg M.C., et al. Truncated apoE forms tangle-like structures in a neuronal cell line. Neuroreport 13 (2002) 867-870
102. Kamino K., et al. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem. Biophys. Res. Commun. 273 (2000) 192-196
103. Hirai K., et al. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci. 21 (2001) 3017-3023
104. Gibson G.E., et al. Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann. Neurol. 48 (2000) 297-303
105. Reiman E.M., et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 284-289
106. Reiman E.M., et al. Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8299-8302
107. Drzezga A., et al. Cerebral glucose metabolism in patients with AD and different APOE genotypes. Neurology 64 (2005) 102-107
108. Mosconi L., et al. Brain metabolic decreases related to the dose of the apoE e4 allele in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 75 (2004) 370-376
109. Hirono N., et al. The effect of APOE ε4 allele on cerebral glucose metabolism in AD is a function of age at onset. Neurology 58 (2002) 743-750
110. Scarmeas N., et al. APOE related alterations in cerebral activation even at college age. J. Neurol. Neurosurg. Psychiatry 76 (2005) 1440-1444
111. Chang S., et al. Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 18694-18699
112. Nakamura T., et al. Apolipoprotein E4 (1-272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells. Mol. Neurodegener. 4 (2009) 35
113. Green M., and Loewenstein P.M. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 55 (1988) 1179-1188
114. Tanaka M., et al. Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4. Biochemistry 45 (2006) 4240-4247
115. Chou C.-Y., et al. Structural and functional variations in human apolipoprotein E3 and E4. J. Biol. Chem. 281 (2006) 13333-13344
116. Risner M.E., et al. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease. Pharmacogenomics J. 6 (2006) 246-254
117. Stokin G.B., et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307 (2005) 1282-1288
118. Ebneth A., et al. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: Implications for Alzheimer's disease. J. Cell Biol. 143 (1998) 777-794
119. Li Z., et al. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119 (2004) 873-887
120. Morris R.L., and Hollenbeck P.J. The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth. J. Cell Sci. 104 (1993) 917-927
121. Reynolds I.J., et al. Mitochondrial trafficking in neurons: a key variable in neurodegeneration?. J. Bioenerg. Biomembr. 36 (2004) 283-286
122. Kim J., et al. The role of apolipoprotein E in Alzheimer's disease. Neuron 63 (2009) 287-303
123. Huang Y. Molecular and cellular mechanisms of apolipoprotein E4 neurotoxicity and potential therapeutic strategies. Curr. Opin. Drug Discov. Devel. 9 (2006) 627-641